InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-0.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Bleil Lynn Dorsey. Officer active across 3 companies, notably Amicus Therapeutics, INC.. Cumulatively, 9 reports have been logged. Split: 2 buys · 0 sell. Total volume traded: €204k. History available since 25 May 2021. The latest transaction was disclosed on 27 April 2026 (Disposition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Bleil Lynn Dorsey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
113,941 shares@ US$14.500.035% mcap77.5% of flowCommon StockSEC:0001193125-26-182273:0
20,414 shares0Common StockSEC:0000950170-25-083203:0
2,465 shares@ US$62.00100.0% of flowCommon StockSEC:0001415889-24-026024:0
11,847 shares0Common StockSEC:0000950170-24-071006:0
8,584 shares0Common StockSEC:0001209191-23-036425:0
12,671 shares0Common StockSEC:0001209191-22-035821:0
10,115 shares0Common StockSEC:0001209191-21-040390:0
28,605 shares@ US$8.7412.7% of flowCommon StockSEC:0001209191-21-036239:0
Canonical exit: 23 Aug 2021 (T+90)
1,500 sharesCommon StockSEC:0001246360-16-004424:0
Canonical exit: 11 May 2016 (T+90)
9 of 9 declarations
About Bleil Lynn Dorsey
Lynn Dorsey Bleil is a director at Amicus Therapeutics, INC.
